Expert Team-Chengdu West China Clinical Research Center Co.,Ltd



Li Weimin

• Director, Respiratory and Co-morbidities Research Institute, West China Hospital, Sichuan University
• Director / Chief Scientist, National Precision Medicine Industry Innovation Center
• Director, Ministry of Education Frontier Science Center for Disease Molecular Network
• Professor & Doctoral Supervisor, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University

Editorial Roles
• Lead Editor, Respiratory System and Diseases (14th Five-Year Plan Clinical Medicine Integrated Textbook Series)
• Editor-in-Chief, Precision Clinical Medicine
• Deputy Editor-in-Chief, Signal Transduction and Targeted Therapy
• Editor-in-Chief, West China Medical Journal
• Deputy Editor-in-Chief, Chinese Journal of Tuberculosis and Respiratory Diseases

Research Grants
• Principal investigator of key projects and general projects of the National Natural Science Foundation of China (NSFC), as well as major national science and technology programs.

Publications
• Author of research papers in high-impact journals including Cell, Nature Biomedical Engineering, and others.
• Awards & Honors
• Second Prize of National Science and Technology Progress Award
• First Prize of Sichuan Provincial Science and Technology Progress Award
• National Innovation Excellence Award
• Tianfu Qingcheng Program – Tianfu Outstanding Scientist
• Wu Jieping – Paul Janssen Medical & Pharmaceutical Award

Chen Lei

• President, Chengdu Second People's Hospital, Sichuan University
• Vice Dean, West China School of Medicine, Sichuan University
• Professor & Doctoral Supervisor, Neurology
• Expert of Science Popularization, China Association for Science and Technology
• National March 8th Red-Banner Pacesetter
• Academic and Technical Leader of Sichuan Province
• Outstanding Young Scientific and Technological Talent of Sichuan Province

Academic Affiliations
• Vice Chair, Youth Committee, China Association Against Epilepsy
• Member, Education Committee, International League Against Epilepsy
• Vice President, Sichuan Association of Women Scientists and Technologists
• Vice Chair, High Altitude Medicine Committee, Sichuan Medical Promotion Association
• Deputy Lead, Clinical Research Group, Scientific Research Management Branch, Chinese Medical Association
• Vice Chair, Health Data and Digital Medicine Branch, China International Exchange and Promotive Association for Medical and Health Care
• Rotating Chair, Artificial Intelligence Medical Device Innovation Cooperation Platform
Research Grants
Principal investigator of 33 funded projects, including 5 NSFC grants (1 key project) and 1 major national science and technology program.

Publications & Patents
• Author of over 100 academic papers as first or corresponding author, including 73 in SCI-indexed journals.
• Lead editor or translator of 6 academic monographs.
• Holder of 9 authorized national invention patents.

Awards & Honors
• 17th China Youth Science and Technology Award
• Sichuan Outstanding Youth Science and Technology Innovation Award
• Tianfu Science and Technology Elite
• Chinese Medical Youth Science and Technology Award
• First Prize of Sichuan Medical Science and Technology Award (Youth Category)
• Most Beautiful Science and Technology Worker of Sichuan Province
• Third Prize of Sichuan Provincial Science and Technology Progress Award
• Two international awards from the Society for Neuroscience (USA) and the American Federation for Medical Research

Li Yuan

• Chairman, Chengdu West China Clinical Research Center Co., Ltd.
• Director, Research Platform Management Office, Department of Science and Technology, West China • Hospital, Sichuan University
• Executive Vice Director, National Precision Medicine Industry Innovation Center
• General Manager, West China Precision Medicine Industry Innovation Center Co., Ltd.
• Deputy Director, Headquarters of the National Major Science and Technology Infrastructure for Translational Medicine, Sichuan University

Education
• M.D., Ph.D. in Biology, Professor
• Postdoctoral Fellow, MBA

Honors & Leadership
• Academic and Technical Leader of Sichuan Province
• Academic and Technical Leader of Sichuan Provincial Health Commission
• Member, Experimental Surgery and Translational Medicine Group, Surgery Branch, Chinese Medical Association
• Chair-Elect, Translational Medicine Committee, Sichuan Medical Association

Niu Qian

• General Manager, Chengdu West China Clinical Research Center Co., Ltd.
• M.D., Chief Technologist, Master’s Supervisor
• Candidate, 15th Batch of Academic and Technical Leaders of Sichuan Province
• Young and Mid‑aged Backbone Talent, Sichuan Provincial “Health Talents Program”
• Overseas High‑Level Returnee of Sichuan Province
• Visiting Scholar, Erasmus MC, the Netherlands

Academic Affiliations
• Member, Clinical Immunology Group, Laboratory Physician Branch, Chinese Medical Doctor Association (5th Council)
• Member, Flow Cytometry Analysis and Diagnostic Expert Committee, Laboratory Medicine Committee, Chinese Association of Integrative Medicine (3rd)
• Youth Member (2nd Council) / Full Member (3rd Council), Laboratory and Diagnostic Branch, Chinese Leprosy Association
• Member, Laboratory Physician Branch, Sichuan Medical Doctor Association (4th Council)

Research Grants
• Principal investigator of 3 NSFC projects, 1 sub‑project of the National Key R&D Program of China, and 1 key R&D project of Sichuan Provincial Department of Science and Technology.
• Participated in over 10 national, provincial, and ministerial research projects.

Publications & Books
• Author of more than 30 papers, including 17 SCI papers as first or corresponding author.
• Contributing author to 2 national textbooks, 6 monographs, and 2 expert consensus documents.
• Co‑translator of 1 international monograph.

Liang Maozhi

Main Research Directions
Clinical pharmacology, in vivo drug analysis, pharmacokinetics in Phase I clinical trials of new drugs

Academic Affiliations
• Standing Committee Member / Advisory Member, Drug Clinical Evaluation Committee, Chinese Pharmacological Society
• Standing Committee Member, Clinical Pharmacology Committee, Chinese Pharmacological Society
• Member, New Drug Review Expert Pool and Inspection Expert Pool, National Medical Products Administration (NMPA)
• Distinguished Lecturer, Advanced Training Institute, NMPA
• Academic and Technical Leader, Sichuan Provincial Health Commission
• New Drug Review and Inspection Expert, Sichuan Medical Products Administration
• Chairman, Drug Clinical Evaluation Committee, Sichuan Pharmaceutical Association
• Vice Chairman, Sichuan Expert Committee on Drug Safety Evaluation
• Deputy Director, Clinical Trial Ethics Committee, West China Hospital, Sichuan University
• Deputy Director, Biomedical Ethics Committee, West China Hospital, Sichuan University

Research Experience
• Completed over 50 Phase I clinical trials
• Completed one “National Major New Drug Development” GCP Platform Construction Project of the Ministry of Science and Technology / National Health and Family Planning Commission (12th Five‑Year Plan)
• Served as project leader for one “National Major New Drug Development” GCP Platform Construction Project (13th Five‑Year Plan)
• Served as project leader for three key science and technology support projects of the Sichuan Provincial Department of Science and Technology

Publications
Author of over 100 academic papers, including 35 as first author or corresponding author, of which 22 are indexed in SCI or Medline.

Liu Zeyuan

• Deputy Director, Clinical Pharmacology Committee, PLA Pharmacy Professional Committee
• Secretary General, Clinical Pharmacology Committee, Chinese Pharmacological Society

Chen Yongchuan

• Director, Drug Clinical Trial Institution Office of The First Affiliated Hospital of Army Medical University (Third Military Medical University)
• Director, Phase I Clinical Trial Research Unit
• Standing Committee Member, Medical Ethics Branch, Chinese Medical Association
• Chairman, Drug Clinical Trial Professional Committee, Chongqing Pharmaceutical Association
• Member, Medical Ethics Expert Committee, National Health Commission
Standing Committee Member, Hospital Pharmacy Professional Committee, Chongqing Pharmaceutical Association
• Member, Clinical Pharmacy Professional Committee, Chongqing Medical Association
• Member, Clinical Pharmacy Committee, PLA
• Standing Committee Member, Drug Clinical Trial Committee, PLA
• Inaugural Chairman, Medical Ethics Professional Committee, Chongqing Medical Association

Research & Projects
• Long dedicated to drug clinical trials and clinical research ethics teaching and research. Aims to align standardized hospital clinical research management and quality with international standards, focusing on institutional development and the standardization of IRB review capacity.
• Completed over 60 new drug clinical studies, including Phase I pharmacokinetics and bioavailability trials.
• Principal investigator of 1 NSFC project, 1 National Major New Drug Development Program, and 5 Chongqing municipal research grants.

Publications & Awards
Recipient of two Military Science and Technology Progress Awards (Second and Third Prizes) and one Second Prize of Chongqing Science and Technology Progress Award.
Author of over 140 papers.
Holder of 5 national invention patents as the lead inventor.

Wang Meixia

• Director, Drug Clinical Trial Institution Office of Beijing Jishuitan Hospital
• Director, Phase I Clinical Trial Research Unit
• Chair, Medical Ethics Review Branch, Beijing Medical Ethics Association
• Expert, Science and Technology Expert Pool, Investment Evaluation Center, Ministry of Finance
• GCP Inspector and Data Verification Panel Expert, National Medical Products Administration (NMPA)
• AAHRPP On‑Site Accreditation Surveyor
• Vice Chair, Clinical Trial Standard Evaluation Branch, Clinical Drug Evaluation Committee, China Association of Medical Education (1st Council)
• Member, Clinical Pharmacology Committee, Beijing Pharmacological Society (2nd Council)
• Auditor, Research Ethics Review System, World Federation of Chinese Medicine Societies
• Member, Drug Safety Evaluation Committee, Beijing Pharmaceutical Association (16th Council)
• Member, Clinical Ethics Group, Medical Ethics Branch, Chinese Medical Association
• Standing Committee Member, Clinical Drug Evaluation Committee, China Association of Medical Education (1st Council)
• Member, Human Subject Protection Group, Drug Clinical Evaluation Research Committee, Chinese Pharmaceutical Association (2nd)
• Auditor, Research Ethics Review System, World Federation of Chinese Medicine Societies
• Member, Drug Clinical Trial Ethics Research Committee, Chinese Pharmaceutical Association (1st)
• Standing Committee Member, Clinical Research Committee, Beijing Oncology Society (1st)
• Member, Drug Clinical Trial Committee, Chinese Pharmacological Society
• Member, Vaccine Clinical Research Committee, Chinese Preventive Medicine Association

Professional Experience
• Since 2009, engaged in GCP management and served as Head of Phase I Clinical Trial Research Unit.
• Main research directions: first‑in‑human safety, tolerability, pharmacokinetics, and pharmacodynamics.

Achievements
• As Project Leader, led Beijing You’an Hospital in applying for AAHRPP accreditation, achieving Full Accreditation in June 2011 – the first hospital in China (including Hong Kong, Macao, and Taiwan) to receive this highest level of accreditation.
• As an AAHRPP site visitor, has completed on‑site inspections of two institutions in China and South Korea.

Lu Qi

• Council Member, Ethics Review Committee, World Federation of Chinese Medicine Societies
• Standing Council Member, Clinical Trial Branch, China Association of Medical Education
• Youth Member, Medical Research Ethics Specialty Branch, Shanghai Medical Association
• Deputy Secretary General, Shanghai Medical Ethics Association
• Appointed Secretary, Shanghai Medical Ethics Expert Committee
• NMPA Ethics Training Instructor, National Medical Products Administration

Research & Publications
• Principal investigator of 6 bureau‑level research projects.
• Author of over 10 papers.
• Contributing author to 3 monographs.
Awards
• Medical Ethics Youth Talent Award, Shanghai Medical Ethics Association (Inaugural, 2015)

Liu Linna

• Director, GCP/IIT Research Office, Clinical Research Center
• Deputy Director, Phase I Research Ward
• Deputy Director, Pharmacy Department

Academic Affiliations
• Member, Drug Clinical Research and Evaluation Committee, Chinese Pharmaceutical Association
• Standing Committee Member, Drug Clinical Trial Research and Evaluation Branch, China Association of Medical Education
• Member, Therapeutic Drug Monitoring Committee, Chinese Pharmacological Society
• Member, Pharmacogenomics Committee, Chinese Pharmacological Society
• Chair, Clinical Evaluation Research Committee, Shaanxi Pharmaceutical Association
• Vice Chair, Clinical Trial and Research Committee, Shaanxi Health Care Association
• Vice Chair, Anti‑Infective Drug Pharmacology Committee, Shaanxi Pharmacological Society
• Vice Chair, Clinical Pharmacology Committee, Shaanxi Pharmaceutical Association

Research Grants
• Principal investigator of 2 general projects of the National Natural Science Foundation of China (NSFC) and 6 Natural Science Foundation projects of Shaanxi Province.

Main Research Directions
• Clinical Pharmacology
• Traditional Chinese Medicine Pharmacology
• Clinical Research and Evaluation of New Drugs / Medical Devices

Publications & Awards
• Author of over 20 SCI papers as first or corresponding author.
• Recipient of First Prize of Shaanxi Provincial Science and Technology Progress Award.
• Published 15 monographs (3 as editor‑in‑chief, 3 as associate editor, 6 as contributing author, 3 as co‑translator), including one national textbook for the "13th Five‑Year Plan" of the National Health Commission (People's Medical Publishing House).
• Honored with a Third‑Class Individual Merit Citation.
• 2018 Science Popularization Star of Chinese Pharmaceutical Association
• 2019 Outstanding Pharmacist of Chinese Pharmaceutical Association
• 2020 Most Beautiful Clinical Pharmacist of Shaanxi Province
• 2021 Outstanding Science and Technology Worker in Pharmacy of Shaanxi Province

Cao Yu

• Chief Pharmacist / Director of GCP Office, The Affiliated Hospital of Qingdao University

Academic Affiliations
• GCP Inspector / CDE Reviewer, National Medical Products Administration (NMPA)
• Vice Chair, Drug Clinical Evaluation Research Committee, Chinese Pharmaceutical Association
• Standing Committee Member, Drug Clinical Trial Committee, Chinese Pharmacological Society
• Vice Chair, Clinical Research Management Committee, China Food and Drug Enterprise Quality and Safety Promotion Association
• Chair, Early Clinical / Bioequivalence Study Committee, ZGC Jiutai GCP Alliance

Main Research Direction
• Clinical Pharmacology

Research Grants
• Participated in 2 major new drug projects of the National Key R&D Program of China
Publications & Awards
• Author of 33 SCI papers
• Contributing author to more than 10 books

Tang Lei

• Chief Pharmacist of The First Affiliated Hospital, Sun Yat‑sen University
• Deputy Director, National Drug Clinical Trial Institution
• Clinical Trial Data Verification Expert / Team Leader, NMPA and Provincial Medical Products Administration
• Managed over 1,000 clinical trials in the past five years

Academic Affiliations
• Chair, Medical Device Clinical Trial Committee, Guangdong Province
• Standing Committee Member, Drug Clinical Trial Committee, Chinese Pharmacological Society
• Member, Drug Clinical Evaluation Research Committee, Chinese Pharmaceutical Association
• Vice Chair, Pharmacovigilance and Drug Reevaluation Committee, Guangdong Pharmacological Society
• Vice Chair, Oncology Drug Committee, Guangdong Pharmaceutical Association
• Standing Committee Member, Drug Clinical Trial Committee, Guangdong Pharmaceutical Association
• Editorial Board Member, Chinese Journal of Clinical Pharmacology, China Pharmaceuticals, Pharmaceutical Research

Publications & Guidelines (Lead)
• Lead Editor: Case Analysis of Off‑Label Drug Use Litigation; Medical Device Clinical Trial Regulations: Analysis, Case Studies, and Question Collection. Contributing author to several other books.
• Lead Contributor to Expert Consensus documents: Handling of Device Defects During Medical Device Clinical Trials; Blind Maintenance in Drug Clinical Trials – Guangdong Consensus; Protection of Informed Consent Rights for Off‑Label Drug Use in Clinical Trials – Guangdong Consensus; Handling of Subject Injury in Drug Clinical Trials – Guangdong Consensus. Contributing author to multiple other consensus documents.

Patents & Software
• 1 invention patent
• 3 software copyrights

Research Grants
• Principal investigator of multiple funds from Guangdong Provincial Department of Science and Technology, Guangdong Medical Science Foundation, and Guangdong Pharmaceutical Association.
• Participated in several NSFC projects.

Publications
• Published over 40 papers in core journals (including SCI) as first or corresponding author.

He Hongchen

• M.D., Chief Physician, Master's Supervisor
• Medical Director, Rehabilitation Medicine Center, West China Hospital, Sichuan University
• Council Member, Sichuan People’s Association for Friendship with Foreign Countries
• Reserve Candidate, Academic and Technical Leader of Sichuan Province
• Member, China International Emergency Medical Team (EMT, Sichuan)
• Member, National Health Science Popularization Expert Pool, National Health Commission

Academic Appointments
• Standing Committee Member & Youth Committee Vice Chair, Pain Rehabilitation Committee, Chinese Association of Rehabilitation Medicine
• President, Rehabilitation Medicine Branch, Sichuan Rehabilitation Medical Association
• Chair, Rehabilitation Physician Committee, Sichuan Rehabilitation Medical Association
• Chair‑Elect, Rehabilitation Physician Committee, Sichuan Medical Doctor Association
• Vice Chair, Integrated Sports Medicine Committee, Sichuan Medical Association
• Vice Chair, Wound Repair Committee, Sichuan Medical Doctor Association

Clinical Expertise
• Interventional rehabilitation of shoulder joints
• Interventional rehabilitation of hip, knee, and ankle joints
• Interventional rehabilitation of the spine

Specialized Techniques
• PRP cartilage repair
• PRP tendon repair
• Ultrasound‑guided interventional therapy

Research Areas
• Regenerative rehabilitation (basic and clinical application of stem cells and PRP)
• Artificial intelligence in rehabilitation

Academic Achievements
• Principal investigator of 7 major projects (including sub‑projects of national key R&D programs and provincial/ministerial grants), with total funding exceeding 2 million RMB.
• Holder of 17 patents (4 as lead inventor).
• Author of 85 papers.
• Lead editor or contributing author of 21 books.

Awards
• First Prize of Huaxia Medical Science and Technology Award
• Second Prize of Ministry of Education Science and Technology Progress Award
• First‑Class Undergraduate Course of Sichuan Province
• Second Prize of West China Hospital New Technology Competition

Translations & Publications (Selected)
• Lead translator of Scapular Dyskinesis and Its Role in Shoulder Injury: Clinical Assessment and Rehabilitation Guide by W. Ben Kibler.
• Contributing author to the English monograph Platelet‑Rich Plasma in Tissue Repair and Regeneration (Springer, global distribution), edited by Academician Fu Xiaobing and Professor Cheng Biao.

Cai Bei

• M.D.
• Chief Technologist and Technical Lead of Clinical Immunology Laboratory, Department of Laboratory Medicine

Academic Affiliations
• Reserve Candidate, 13th Batch of Academic and Technical Leaders of Sichuan Province
• Young and Mid‑aged Backbone Talent, Sichuan Provincial “Health Talents Program” (2023)
• Member, Flow Cytometry Analysis and Diagnostic Expert Committee, Laboratory Medicine Committee, Chinese Association of Integrative Medicine

Research Grants
• Principal investigator of 1 NSFC project and 2 projects of Sichuan Provincial Department of Science and Technology.
• As a top‑three key researcher, participated in 11 NSFC projects, 2 Ministry of Education projects, and 4 projects of Sichuan Provincial Department of Science and Technology.

Publications
• Author of 23 papers as first, co‑first, or corresponding author, including 15 SCI indexed.

Main Research Direction
• Cellular immune regulation mechanisms related to autoimmunity, transplantation immunity, and infection immunity, as well as laboratory diagnostic studies of immunological markers.

 